BioCancell Therapeutics to Commence Enrollment of Phase IIb Pancreatic Cancer Clinical Trial
10/6/2011 10:17:17 AM
More...
|
BioCancell Therapeutics Successfully Raises $5.1 Million in Public Offering
11/23/2010 6:59:09 AM
More...
|
Tikcro Technologies Announces Results of BioCancell Therapeutics' US FDA Phase I/IIa Pancreatic Cancer Trial
11/2/2010 10:17:46 AM
More...
|
BioCancell Therapeutics Announces Success in Phase I/IIa Pancreatic Cancer Clinical Trial
11/1/2010 11:42:47 AM
More...
|
Tikcro Technologies Announced BioCancell Therapeutics Receives U.S. FDA Approval to Continue Phase IIb Superficial Bladder Cancer Clinical Trial and Interim Results
4/30/2010 11:04:30 AM
More...
|
US Department of Health and Human Services Grants Orphan Drug Status to BioCancell Therapeutics's Ovarian Cancer Drug
8/24/2009 10:57:06 AM
More...
|
USA FDA Allows BioCancell Therapeutics to Commence Phase I/IIa Ovarian and Pancreatic Clinical Trials
1/14/2009 10:21:21 AM
More...
|
VGX International Signs a Master Product Sale Agreement with BioCancell Therapeutics of Israel to Supply Plasmid for Its Multiple Clinical Programs
10/27/2008 11:17:26 AM
More...
|
Tikcro Technologies Closes Funding into BioCancell Therapeutics
7/31/2008 9:48:18 AM
More...
|
Tikcro Technologies Allocates $2.5 Million of Funding into BioCancell Therapeutics
6/23/2008 11:27:48 AM
More...
|